Speaker
Senior Vice President of Discovery Biology, PTC Therapeutics
Christopher Trotta, Senior Vice President of Discovery Biology at PTC Therapeutics, is speaking at 9th RNA-Targeted Drug Discovery & Development Summit (Boston, United States of America, 10–12 Nov 2026) in the session “Mechanistic Insights into Splicing Modulation to Define RNA–Small Molecule Interactions & Unlock Targetable Splice Sequences”.
10–12 Nov 2026Boston, United States of America
Associate Director, Early Discovery Chemistry, PTC Therapeutics
Professor & Associate Chair of Graduate Affairs, University of Colorado Boulder
Chief Scientific Officer, Dewpoint Therapeutics
Head of Cancer Biology, EPICS Therapeutics
Senior Principal Scientist & Research Fellow, Pfizer
Head of Small Molecules Medicinal Chemistry, Sanofi
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Christopher Trotta, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].